# ğŸ† ULTIMATE MOAT: END-TO-END AGENTIC ONCOLOGY ORCHESTRATION

**Purpose:** Blueprint for the complete CrisPRO.ai product workflow - from data upload to continuous care orchestration with agentic intelligence.

**Last Updated:** December 3, 2025  
**Status:** MASTER BLUEPRINT | Priority: CRITICAL

---

## ğŸ¯ THE VISION

> **"Upload once. Track forever. Never miss a signal."**

A patient's genomic data enters the system once. From that moment, an agentic swarm takes over - calculating biomarkers, predicting resistance, matching trials, generating nutrition plans, and continuously monitoring for signals that require action. The oncologist receives actionable intelligence, not raw data.

---

## ğŸ“Š THE COMPLETE MOAT STACK

### Layer 1: Validated Biomarker Capabilities

| Capability | Validation | Status | What It Does |
|------------|------------|--------|--------------|
| **TMB Calculation** | r=0.933, 95.4% accuracy | âœ… Production | Calculate TMB from mutations |
| **TMB-H Classification** | Validated against TCGA | âœ… Production | Classify IO eligibility (â‰¥10 mut/Mb) |
| **MAPK Resistance** | RR=1.97, p<0.05 | âœ… Production | Predict platinum resistance |
| **MSI Detection** | Logic ready | â³ Need data | Detect dMMR/MSI-H |
| **HRD Inference** | MBD4 + BRCA logic | âœ… Production | Infer PARP eligibility |

### Layer 2: Clinical Intelligence Capabilities

| Capability | Source | Status | What It Does |
|------------|--------|--------|--------------|
| **Toxicity-Nutrition** | Drug MoA + Food DB | âœ… Production | Protective nutrition per drug |
| **Trial Matching** | ClinicalTrials.gov API | âœ… Production | Match patient to trials |
| **SOC Recommendations** | NCCN Guidelines | âœ… Production | Standard of care with confidence |
| **Drug Efficacy (S/P/E)** | Evo2 + Pathway + Evidence | âœ… Production | Per-drug efficacy ranking |

### Layer 3: Agentic Monitoring Capabilities

| Capability | Trigger | Status | What It Does |
|------------|---------|--------|--------------|
| **CA-125 Kinetics** | >25% rise | ğŸ”„ Building | Early resistance detection |
| **ctDNA Monitoring** | Variant reappearance | ğŸ”„ Building | MRD detection |
| **Treatment Response** | RECIST criteria | ğŸ”„ Building | Response classification |
| **Adverse Events** | CTCAE grading | ğŸ”„ Building | Toxicity monitoring |

---

## ğŸ”„ THE MASTER WORKFLOW

### Phase 0: Data Upload & Ingestion

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                         DATA UPLOAD PORTAL                               â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                          â”‚
â”‚  ğŸ“¤ UPLOAD PATIENT DATA                                                  â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”    â”‚
â”‚  â”‚  Drag & drop or click to upload:                                â”‚    â”‚
â”‚  â”‚  â€¢ NGS Report (VCF, MAF, PDF, JSON)                            â”‚    â”‚
â”‚  â”‚  â€¢ Clinical Notes (PDF, TXT)                                    â”‚    â”‚
â”‚  â”‚  â€¢ Lab Results (PDF, CSV)                                       â”‚    â”‚
â”‚  â”‚  â€¢ Imaging Reports (PDF)                                        â”‚    â”‚
â”‚  â”‚  â€¢ Pathology Report (PDF)                                       â”‚    â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜    â”‚
â”‚                                                                          â”‚
â”‚  ğŸ“‹ OR ENTER MANUALLY:                                                   â”‚
â”‚  â€¢ Gene/Variant: [BRAF V600E        ]                                   â”‚
â”‚  â€¢ Disease:      [Multiple Myeloma  â–¼]                                  â”‚
â”‚  â€¢ Stage:        [III              â–¼]                                   â”‚
â”‚                                                                          â”‚
â”‚  [ğŸš€ INITIATE FULL ANALYSIS]                                            â”‚
â”‚                                                                          â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### Phase 1: Agentic Data Extraction

**Trigger:** File upload detected

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  ğŸ¤– DATA EXTRACTION AGENT                                        â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                  â”‚
â”‚  Input: Raw file (NGS PDF, VCF, etc.)                           â”‚
â”‚                                                                  â”‚
â”‚  Actions:                                                        â”‚
â”‚  1. Detect file type (PDF, VCF, MAF, JSON)                      â”‚
â”‚  2. Parse mutations (gene, variant, VAF, coverage)              â”‚
â”‚  3. Extract clinical data (stage, histology, biomarkers)        â”‚
â”‚  4. Extract demographics (age, sex, ECOG)                       â”‚
â”‚  5. Validate data quality (missing fields, coverage thresholds) â”‚
â”‚  6. Flag ambiguities for human review                           â”‚
â”‚                                                                  â”‚
â”‚  Output: Structured PatientProfile object                        â”‚
â”‚                                                                  â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚  â”‚  PatientProfile:                                           â”‚ â”‚
â”‚  â”‚    patient_id: "AYE-001"                                   â”‚ â”‚
â”‚  â”‚    disease: "ovarian_cancer"                               â”‚ â”‚
â”‚  â”‚    histology: "high_grade_serous"                          â”‚ â”‚
â”‚  â”‚    stage: "IVB"                                            â”‚ â”‚
â”‚  â”‚    mutations: [                                            â”‚ â”‚
â”‚  â”‚      { gene: "MBD4", variant: "c.1239delA", zygosity: "hom"}â”‚ â”‚
â”‚  â”‚      { gene: "TP53", variant: "R175H", source: "IHC" }     â”‚ â”‚
â”‚  â”‚    ]                                                       â”‚ â”‚
â”‚  â”‚    germline_panel: { brca1: "negative", brca2: "negative" }â”‚ â”‚
â”‚  â”‚    data_quality_flags: ["hrd_pending", "ca125_missing"]    â”‚ â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚                                                                  â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### Phase 2: Biomarker Calculation Pipeline

**Trigger:** PatientProfile extracted

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  ğŸ§¬ BIOMARKER CALCULATION AGENT                                  â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                  â”‚
â”‚  Input: PatientProfile.mutations[]                               â”‚
â”‚                                                                  â”‚
â”‚  Parallel Calculations:                                          â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚  â”‚  TMB CALCULATION                                           â”‚ â”‚
â”‚  â”‚  â€¢ Count nonsynonymous mutations                           â”‚ â”‚
â”‚  â”‚  â€¢ Divide by exome size (38 Mb)                           â”‚ â”‚
â”‚  â”‚  â€¢ Result: 3.2 mut/Mb â†’ TMB-L                             â”‚ â”‚
â”‚  â”‚  â€¢ Validation: r=0.933 vs TCGA                            â”‚ â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚  â”‚  MSI DETECTION                                             â”‚ â”‚
â”‚  â”‚  â€¢ Check dMMR genes: MLH1, MSH2, MSH6, PMS2, EPCAM        â”‚ â”‚
â”‚  â”‚  â€¢ Result: No dMMR mutations â†’ MSS                        â”‚ â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚  â”‚  HRD INFERENCE                                             â”‚ â”‚
â”‚  â”‚  â€¢ Check HRR genes: BRCA1/2, ATM, ATR, PALB2, RAD51       â”‚ â”‚
â”‚  â”‚  â€¢ Check BER genes: MBD4 â† FOUND!                         â”‚ â”‚
â”‚  â”‚  â€¢ MBD4 homozygous loss â†’ BER deficiency â†’ HRD-like       â”‚ â”‚
â”‚  â”‚  â€¢ Result: HRD-INFERRED (awaiting Myriad score)           â”‚ â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚  â”‚  IO ELIGIBILITY                                            â”‚ â”‚
â”‚  â”‚  â€¢ TMB-H (â‰¥10)? NO                                        â”‚ â”‚
â”‚  â”‚  â€¢ MSI-H? NO                                              â”‚ â”‚
â”‚  â”‚  â€¢ Result: IO NOT ELIGIBLE (by current biomarkers)        â”‚ â”‚
â”‚  â”‚  â€¢ Note: MBD4 loss may cause elevated TMB - pending NGS   â”‚ â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚                                                                  â”‚
â”‚  Output: BiomarkerProfile                                        â”‚
â”‚  {                                                               â”‚
â”‚    tmb: 3.2,                                                    â”‚
â”‚    tmb_classification: "TMB-L",                                 â”‚
â”‚    msi_status: "MSS",                                           â”‚
â”‚    hrd_status: "HRD-INFERRED",                                  â”‚
â”‚    hrd_mechanism: "MBD4_BER_DEFICIENCY",                        â”‚
â”‚    io_eligible: false,                                          â”‚
â”‚    parp_eligible: true,                                         â”‚
â”‚    validation_provenance: {                                      â”‚
â”‚      tmb: "TCGA Pan-Immune r=0.933"                             â”‚
â”‚    }                                                            â”‚
â”‚  }                                                               â”‚
â”‚                                                                  â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### Phase 3: Resistance Prediction

**Trigger:** BiomarkerProfile calculated

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  âš”ï¸ RESISTANCE PREDICTION AGENT                                  â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                  â”‚
â”‚  Input: PatientProfile.mutations[], current_treatment            â”‚
â”‚                                                                  â”‚
â”‚  Pathway Analysis:                                               â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚  â”‚  MAPK PATHWAY CHECK (Validated RR=1.97)                    â”‚ â”‚
â”‚  â”‚  â€¢ KRAS: Not detected                                      â”‚ â”‚
â”‚  â”‚  â€¢ NRAS: Not detected                                      â”‚ â”‚
â”‚  â”‚  â€¢ BRAF: Not detected                                      â”‚ â”‚
â”‚  â”‚  â€¢ NF1: Not detected                                       â”‚ â”‚
â”‚  â”‚  â€¢ MEK1/2: Not detected                                    â”‚ â”‚
â”‚  â”‚  â†’ MAPK pathway: WILD-TYPE                                 â”‚ â”‚
â”‚  â”‚  â†’ Platinum resistance risk: BASELINE (14.5%)              â”‚ â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚  â”‚  DDR PATHWAY CHECK                                         â”‚ â”‚
â”‚  â”‚  â€¢ MBD4: HOMOZYGOUS LOSS â­                                â”‚ â”‚
â”‚  â”‚  â€¢ TP53: MUTANT (IHC)                                      â”‚ â”‚
â”‚  â”‚  â†’ DDR pathway: SEVERELY COMPROMISED                       â”‚ â”‚
â”‚  â”‚  â†’ Platinum sensitivity: HIGH (BER deficiency)             â”‚ â”‚
â”‚  â”‚  â†’ PARP sensitivity: VERY HIGH (synthetic lethality)       â”‚ â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚                                                                  â”‚
â”‚  Output: ResistancePrediction                                    â”‚
â”‚  {                                                               â”‚
â”‚    platinum_sensitivity: "HIGH",                                 â”‚
â”‚    platinum_resistance_risk: 0.145,  // Baseline                â”‚
â”‚    parp_sensitivity: "VERY_HIGH",                               â”‚
â”‚    parp_resistance_risk: 0.10,                                  â”‚
â”‚    mechanism: "MBD4_TP53_SYNTHETIC_LETHALITY",                  â”‚
â”‚    signals_detected: 0,  // No MAPK mutations                   â”‚
â”‚    monitoring_priority: ["MAPK_mutations", "ABCB1_expression"], â”‚
â”‚    validation: "TCGA-OV 469 patients, MAPK RR=1.97"             â”‚
â”‚  }                                                               â”‚
â”‚                                                                  â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### Phase 4: Drug Efficacy Ranking (S/P/E)

**Trigger:** ResistancePrediction complete

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  ğŸ’Š DRUG EFFICACY AGENT (S/P/E Framework)                        â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                  â”‚
â”‚  Input: PatientProfile, BiomarkerProfile, ResistancePrediction   â”‚
â”‚                                                                  â”‚
â”‚  S/P/E Calculation per Drug:                                     â”‚
â”‚  Formula: efficacy = 0.3*S + 0.4*P + 0.3*E + clinvar_prior      â”‚
â”‚                                                                  â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚  â”‚  DRUG: OLAPARIB (PARP Inhibitor)                          â”‚ â”‚
â”‚  â”‚  S (Sequence): Evo2 delta for MBD4 c.1239delA = -2.3      â”‚ â”‚
â”‚  â”‚  P (Pathway): DDR pathway burden = 0.92                    â”‚ â”‚
â”‚  â”‚  E (Evidence): 127 papers, 3 RCTs (SOLO1, PRIMA, PAOLA)   â”‚ â”‚
â”‚  â”‚  ClinVar: Pathogenic (MBD4 frameshift)                     â”‚ â”‚
â”‚  â”‚  â†’ Efficacy Score: 0.94 â­ HIGHEST                         â”‚ â”‚
â”‚  â”‚  â†’ Confidence: HIGH (multiple RCTs)                        â”‚ â”‚
â”‚  â”‚  â†’ Tier: I (On-label for HRD+)                            â”‚ â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚  â”‚  DRUG: CARBOPLATIN (Platinum)                              â”‚ â”‚
â”‚  â”‚  S (Sequence): Evo2 delta for TP53 R175H = -1.8           â”‚ â”‚
â”‚  â”‚  P (Pathway): DDR pathway burden = 0.92                    â”‚ â”‚
â”‚  â”‚  E (Evidence): Standard of care, 1000+ papers             â”‚ â”‚
â”‚  â”‚  â†’ Efficacy Score: 0.88                                    â”‚ â”‚
â”‚  â”‚  â†’ Confidence: VERY HIGH (SOC)                            â”‚ â”‚
â”‚  â”‚  â†’ Tier: I (First-line SOC)                               â”‚ â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚  â”‚  DRUG: PEMBROLIZUMAB (Checkpoint Inhibitor)                â”‚ â”‚
â”‚  â”‚  S (Sequence): N/A (IO mechanism)                          â”‚ â”‚
â”‚  â”‚  P (Pathway): IO pathway = 0.0 (TMB-L, MSS)               â”‚ â”‚
â”‚  â”‚  E (Evidence): 45 papers, but not for TMB-L/MSS           â”‚ â”‚
â”‚  â”‚  â†’ Efficacy Score: 0.32                                    â”‚ â”‚
â”‚  â”‚  â†’ Confidence: LOW (no IO biomarker)                       â”‚ â”‚
â”‚  â”‚  â†’ Tier: III (Research only)                              â”‚ â”‚
â”‚  â”‚  âš ï¸ NOTE: Pending TMB from NGS - may change               â”‚ â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚                                                                  â”‚
â”‚  Output: DrugRanking[]                                           â”‚
â”‚  [                                                               â”‚
â”‚    { drug: "Olaparib", efficacy: 0.94, tier: "I", conf: "HIGH" }â”‚
â”‚    { drug: "Carboplatin", efficacy: 0.88, tier: "I", conf: "VH" }â”‚
â”‚    { drug: "Niraparib", efficacy: 0.91, tier: "I", conf: "HIGH" }â”‚
â”‚    { drug: "Bevacizumab", efficacy: 0.72, tier: "II", conf: "M" }â”‚
â”‚    { drug: "Pembrolizumab", efficacy: 0.32, tier: "III", conf: "L"}â”‚
â”‚  ]                                                               â”‚
â”‚                                                                  â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### Phase 5: Trial Matching

**Trigger:** DrugRanking complete

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  ğŸ”¬ TRIAL MATCHING AGENT                                         â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                  â”‚
â”‚  Input: PatientProfile, BiomarkerProfile, 7D MechanismVector     â”‚
â”‚                                                                  â”‚
â”‚  Mechanism Vector (7D):                                          â”‚
â”‚  [DDR=0.92, MAPK=0.0, PI3K=0.15, VEGF=0.10, HER2=0.0, IO=0.0, Efflux=0.0]â”‚
â”‚                                                                  â”‚
â”‚  Query Generation:                                               â”‚
â”‚  â€¢ "MBD4 mutation ovarian cancer clinical trial"                â”‚
â”‚  â€¢ "BER deficiency PARP inhibitor trial"                        â”‚ â”‚
â”‚  â€¢ "DNA repair deficiency basket trial"                         â”‚
â”‚  â€¢ "TP53 mutant ovarian cancer trial"                           â”‚
â”‚  â€¢ "HRD positive maintenance therapy trial"                     â”‚
â”‚                                                                  â”‚
â”‚  Mechanism Fit Ranking:                                          â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚  â”‚  NCT05678901: PARP + ATR Inhibitor in DDR-Deficient OC    â”‚ â”‚
â”‚  â”‚  â€¢ Trial MoA Vector: [DDR=0.95, MAPK=0.0, ...]            â”‚ â”‚
â”‚  â”‚  â€¢ Mechanism Fit: 0.94 â­                                  â”‚ â”‚
â”‚  â”‚  â€¢ Eligibility: 0.92                                       â”‚ â”‚
â”‚  â”‚  â€¢ Combined Score: 0.93                                    â”‚ â”‚
â”‚  â”‚  â€¢ Why Matched: DDR pathway alignment (0.95 vs 0.92)      â”‚ â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚  â”‚  NCT04729387: Olaparib + Cediranib vs Olaparib            â”‚ â”‚
â”‚  â”‚  â€¢ Trial MoA Vector: [DDR=0.90, VEGF=0.70, ...]           â”‚ â”‚
â”‚  â”‚  â€¢ Mechanism Fit: 0.88                                     â”‚ â”‚
â”‚  â”‚  â€¢ Eligibility: 0.95                                       â”‚ â”‚
â”‚  â”‚  â€¢ Combined Score: 0.90                                    â”‚ â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚                                                                  â”‚
â”‚  Output: TrialMatches[]                                          â”‚
â”‚  [                                                               â”‚
â”‚    { nct_id: "NCT05678901", mechanism_fit: 0.94, ... },         â”‚
â”‚    { nct_id: "NCT04729387", mechanism_fit: 0.88, ... },         â”‚
â”‚    { nct_id: "NCT05238922", mechanism_fit: 0.85, ... },         â”‚
â”‚  ]                                                               â”‚
â”‚                                                                  â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### Phase 6: Toxicity-Aware Nutrition

**Trigger:** Treatment plan finalized

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  ğŸ¥— TOXICITY-NUTRITION AGENT                                     â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                  â”‚
â”‚  Input: TreatmentPlan.drugs[], PatientProfile.germline           â”‚
â”‚                                                                  â”‚
â”‚  Analysis per Drug:                                              â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚  â”‚  DRUG: CARBOPLATIN                                         â”‚ â”‚
â”‚  â”‚  MoA: DNA crosslinks â†’ DDR pathway stress                  â”‚ â”‚
â”‚  â”‚  Germline: MBD4 homozygous (BER deficiency)               â”‚ â”‚
â”‚  â”‚  Combined Stress: EXTREME (no BER backup)                  â”‚ â”‚
â”‚  â”‚                                                            â”‚ â”‚
â”‚  â”‚  Recommendations:                                          â”‚ â”‚
â”‚  â”‚  âœ… NAC 600mg: Post-infusion (glutathione precursor)      â”‚ â”‚
â”‚  â”‚  âœ… Vitamin D 2000 IU: Daily (DNA repair support)         â”‚ â”‚
â”‚  â”‚  âœ… Omega-3 2g: Daily (anti-inflammatory)                 â”‚ â”‚
â”‚  â”‚  âœ… Zinc 15mg: Daily (enzyme cofactor)                    â”‚ â”‚
â”‚  â”‚  âš ï¸ AVOID during infusion: High-dose antioxidants        â”‚ â”‚
â”‚  â”‚  âš ï¸ AVOID: Grapefruit (CYP3A4 interaction)               â”‚ â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚  â”‚  DRUG: OLAPARIB (Maintenance)                              â”‚ â”‚
â”‚  â”‚  MoA: PARP inhibition â†’ synthetic lethality with BER      â”‚ â”‚
â”‚  â”‚  Germline: MBD4 homozygous (FAVORABLE for PARP)           â”‚ â”‚
â”‚  â”‚                                                            â”‚ â”‚
â”‚  â”‚  Recommendations:                                          â”‚ â”‚
â”‚  â”‚  âœ… Folate 400mcg: Daily (one-carbon metabolism)          â”‚ â”‚
â”‚  â”‚  âœ… B12 1000mcg: Weekly (hematologic support)             â”‚ â”‚
â”‚  â”‚  âœ… Protein 1.2g/kg: Daily (recovery support)             â”‚ â”‚
â”‚  â”‚  âš ï¸ Monitor: Anemia, fatigue                              â”‚ â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚                                                                  â”‚
â”‚  Output: NutritionPlan                                           â”‚
â”‚  {                                                               â”‚
â”‚    daily_supplements: [...],                                     â”‚
â”‚    timing_rules: [...],                                         â”‚
â”‚    foods_to_avoid: [...],                                       â”‚
â”‚    foods_to_prioritize: [...],                                  â”‚
â”‚    drug_food_interactions: [...]                                â”‚
â”‚  }                                                               â”‚
â”‚                                                                  â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### Phase 7: Unified Care Plan Generation

**Trigger:** All agent outputs ready

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  ğŸ“‹ CARE PLAN ORCHESTRATOR AGENT                                 â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                  â”‚
â”‚  Inputs:                                                         â”‚
â”‚  â€¢ PatientProfile                                                â”‚
â”‚  â€¢ BiomarkerProfile                                              â”‚
â”‚  â€¢ ResistancePrediction                                          â”‚
â”‚  â€¢ DrugRanking[]                                                 â”‚
â”‚  â€¢ TrialMatches[]                                                â”‚
â”‚  â€¢ NutritionPlan                                                 â”‚
â”‚                                                                  â”‚
â”‚  Output: UnifiedCarePlan                                         â”‚
â”‚                                                                  â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚  â”‚  ğŸ©º AYESHA KIANI - UNIFIED CARE PLAN                       â”‚ â”‚
â”‚  â”‚  Generated: December 3, 2025                               â”‚ â”‚
â”‚  â”‚  Confidence: HIGH (all MOATs aligned)                      â”‚ â”‚
â”‚  â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤ â”‚
â”‚  â”‚                                                            â”‚ â”‚
â”‚  â”‚  ğŸ“Š MOLECULAR PROFILE                                      â”‚ â”‚
â”‚  â”‚  â€¢ MBD4 c.1239delA (homozygous) â†’ BER deficiency          â”‚ â”‚
â”‚  â”‚  â€¢ TP53 mutant (IHC) â†’ Checkpoint bypass                  â”‚ â”‚
â”‚  â”‚  â€¢ TMB: Pending NGS (expect elevated due to MBD4)         â”‚ â”‚
â”‚  â”‚  â€¢ HRD: Inferred from MBD4 (awaiting Myriad score)        â”‚ â”‚
â”‚  â”‚                                                            â”‚ â”‚
â”‚  â”‚  ğŸ’Š TREATMENT RECOMMENDATIONS                              â”‚ â”‚
â”‚  â”‚  1. NEOADJUVANT: Carboplatin/Paclitaxel (Efficacy: 0.88)  â”‚ â”‚
â”‚  â”‚  2. MAINTENANCE: Olaparib (Efficacy: 0.94) â­             â”‚ â”‚
â”‚  â”‚  3. BACKUP: ATR inhibitor trial if resistance             â”‚ â”‚
â”‚  â”‚                                                            â”‚ â”‚
â”‚  â”‚  âš”ï¸ RESISTANCE MONITORING                                  â”‚ â”‚
â”‚  â”‚  â€¢ Baseline risk: 14.5% (no MAPK mutations)               â”‚ â”‚
â”‚  â”‚  â€¢ Watch for: MAPK pathway mutations in ctDNA             â”‚ â”‚
â”‚  â”‚  â€¢ CA-125 kinetics: Alert if >25% rise                    â”‚ â”‚
â”‚  â”‚                                                            â”‚ â”‚
â”‚  â”‚  ğŸ”¬ CLINICAL TRIALS                                        â”‚ â”‚
â”‚  â”‚  1. NCT05678901: PARP + ATR (Fit: 0.94) - ENROLLING      â”‚ â”‚
â”‚  â”‚  2. NCT04729387: Olaparib + Cediranib (Fit: 0.88)        â”‚ â”‚
â”‚  â”‚                                                            â”‚ â”‚
â”‚  â”‚  ğŸ¥— NUTRITION PLAN                                         â”‚ â”‚
â”‚  â”‚  â€¢ During chemo: NAC 600mg post-infusion                  â”‚ â”‚
â”‚  â”‚  â€¢ Maintenance: Folate, B12, high protein                 â”‚ â”‚
â”‚  â”‚  â€¢ Avoid: Grapefruit (CYP3A4)                            â”‚ â”‚
â”‚  â”‚                                                            â”‚ â”‚
â”‚  â”‚  ğŸ“… MONITORING SCHEDULE                                    â”‚ â”‚
â”‚  â”‚  â€¢ CA-125: Every 3 weeks during chemo                     â”‚ â”‚
â”‚  â”‚  â€¢ CT: After cycle 3, post-surgery, q3 months            â”‚ â”‚
â”‚  â”‚  â€¢ ctDNA: Baseline + monthly during maintenance           â”‚ â”‚
â”‚  â”‚                                                            â”‚ â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚                                                                  â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### Phase 8: Continuous Monitoring & Alerts

**Trigger:** Care plan active + new data received

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  ğŸ”” MONITORING & ALERT AGENT                                     â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                  â”‚
â”‚  Active Monitors:                                                â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚  â”‚  CA-125 KINETICS MONITOR                                   â”‚ â”‚
â”‚  â”‚  â€¢ Baseline: Pending                                       â”‚ â”‚
â”‚  â”‚  â€¢ Alert threshold: >25% rise from nadir                  â”‚ â”‚
â”‚  â”‚  â€¢ Lead time: 3-6 weeks before clinical progression       â”‚ â”‚
â”‚  â”‚  â€¢ Status: â³ AWAITING BASELINE                            â”‚ â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚  â”‚  ctDNA MUTATION MONITOR                                    â”‚ â”‚
â”‚  â”‚  â€¢ Watch genes: KRAS, NRAS, BRAF, NF1, ABCB1              â”‚ â”‚
â”‚  â”‚  â€¢ Alert: New mutation detected                           â”‚ â”‚
â”‚  â”‚  â€¢ Action: Flag resistance, suggest alternatives          â”‚ â”‚
â”‚  â”‚  â€¢ Status: â³ AWAITING BASELINE ctDNA                      â”‚ â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚  â”‚  TREATMENT RESPONSE MONITOR                                â”‚ â”‚
â”‚  â”‚  â€¢ Criteria: RECIST 1.1                                   â”‚ â”‚
â”‚  â”‚  â€¢ Alert: PD (progressive disease)                        â”‚ â”‚
â”‚  â”‚  â€¢ Action: Trigger resistance analysis, trial re-match    â”‚ â”‚
â”‚  â”‚  â€¢ Status: â³ AWAITING POST-C3 CT                          â”‚ â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚  â”‚  NEW TRIAL MONITOR                                         â”‚ â”‚
â”‚  â”‚  â€¢ Keywords: MBD4, BER deficiency, DDR basket             â”‚ â”‚
â”‚  â”‚  â€¢ Alert: New matching trial opens                        â”‚ â”‚
â”‚  â”‚  â€¢ Action: Notify oncologist, add to options              â”‚ â”‚
â”‚  â”‚  â€¢ Status: âœ… ACTIVE                                       â”‚ â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚                                                                  â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## ğŸš¨ EVENT TRIGGERS & AUTOMATED RESPONSES

### Trigger System Architecture

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                         EVENT TRIGGER SYSTEM                             â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                          â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”    â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”    â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”    â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚  â”‚ DATA INPUT  â”‚â”€â”€â”€â–¶â”‚  DETECTOR   â”‚â”€â”€â”€â–¶â”‚  EVALUATOR  â”‚â”€â”€â”€â–¶â”‚  ACTION  â”‚ â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜    â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜    â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜    â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚                                                                          â”‚
â”‚  Data Sources:                                                           â”‚
â”‚  â€¢ Lab results (CA-125, CBC, etc.)                                      â”‚
â”‚  â€¢ Imaging reports (CT, PET)                                            â”‚
â”‚  â€¢ ctDNA results                                                         â”‚
â”‚  â€¢ New NGS data                                                          â”‚
â”‚  â€¢ Clinical notes                                                        â”‚
â”‚  â€¢ ClinicalTrials.gov API                                               â”‚
â”‚                                                                          â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### Trigger Definitions

```yaml
TRIGGERS:

  # 1. RESISTANCE DETECTED
  resistance_detected:
    condition: "CA-125 > baseline * 1.25 OR MAPK_mutation_in_ctDNA"
    severity: HIGH
    actions:
      - notify_oncologist:
          channel: [email, sms, dashboard]
          message: "Resistance signal detected for {patient_name}"
      - run_resistance_analysis:
          compare_to: baseline
      - suggest_alternatives:
          exclude: current_drug
          prioritize: mechanism_fit
      - re_match_trials:
          keywords: [resistance, salvage, combination]
    escalation:
      if_no_response: 24h
      escalate_to: tumor_board

  # 2. TMB-HIGH DETECTED
  tmb_high_detected:
    condition: "TMB >= 10.0"
    severity: MEDIUM
    actions:
      - update_io_eligibility:
          set: true
      - notify_oncologist:
          message: "Patient now IO-eligible (TMB-H: {tmb} mut/Mb)"
      - re_rank_drugs:
          boost: [pembrolizumab, nivolumab, ipilimumab]
      - match_io_trials:
          keywords: [checkpoint, immunotherapy, TMB-high]

  # 3. MSI-HIGH DETECTED
  msi_high_detected:
    condition: "MSI_status == 'MSI-H' OR dMMR_detected"
    severity: MEDIUM
    actions:
      - update_io_eligibility:
          set: true
      - notify_oncologist:
          message: "MSI-H detected - IO eligible regardless of cancer type"
      - re_rank_drugs:
          boost: [pembrolizumab]
          note: "Pembrolizumab FDA-approved for MSI-H"
      - flag_family:
          reason: "Lynch syndrome screening recommended"

  # 4. HRD SCORE RECEIVED
  hrd_score_received:
    condition: "hrd_score IS NOT NULL"
    severity: LOW
    actions:
      - if: "hrd_score >= 42"
        then:
          - confirm_parp_eligibility:
              confidence: HIGH
          - notify_oncologist:
              message: "HRD+ confirmed (score: {hrd_score}) - PARP eligible"
      - if: "hrd_score < 42"
        then:
          - update_parp_eligibility:
              status: "CONSIDER_ANYWAY"
              reason: "MBD4 BER deficiency is distinct mechanism"
          - notify_oncologist:
              message: "HRD- but MBD4 loss suggests PARP may still work"

  # 5. NEW MATCHING TRIAL
  new_trial_available:
    condition: "trial_match_score >= 0.80 AND trial_status == 'RECRUITING'"
    severity: LOW
    actions:
      - add_to_dashboard:
          section: trials
      - notify_oncologist:
          message: "New trial match: {trial_title} (Fit: {mechanism_fit})"
      - check_eligibility:
          patient: current
          trial: new_trial

  # 6. ADVERSE EVENT REPORTED
  adverse_event_reported:
    condition: "ctcae_grade >= 2"
    severity: HIGH if grade >= 3 else MEDIUM
    actions:
      - log_event:
          grade: ctcae_grade
          type: event_type
      - if: "event_type == 'hematologic'"
        then:
          - suggest_supportive:
              options: [dose_reduction, growth_factors, transfusion]
      - update_nutrition:
          based_on: event_type
      - if: "ctcae_grade >= 3"
        then:
          - escalate_to_oncologist:
              urgent: true

  # 7. TREATMENT RESPONSE
  treatment_response:
    condition: "recist_assessment IS NOT NULL"
    actions:
      - if: "response == 'CR' OR response == 'PR'"
        then:
          - celebrate:
              message: "Good response! Continue current plan."
          - update_plan:
              action: continue
      - if: "response == 'SD'"
        then:
          - monitor_closely:
              increase_frequency: true
      - if: "response == 'PD'"
        then:
          - trigger: resistance_detected
          - recommend_switch:
              to: next_line_therapy
          - re_match_trials:
              keywords: [progressive, refractory, salvage]

  # 8. NGS RESULTS RECEIVED
  ngs_results_received:
    condition: "ngs_report IS NOT NULL"
    severity: HIGH
    actions:
      - parse_mutations:
          source: ngs_report
      - recalculate_all:
          tmb: true
          msi: true
          resistance: true
          drug_ranking: true
      - check_new_mutations:
          compare_to: baseline
      - notify_oncologist:
          message: "NGS results processed. {n_mutations} mutations found."
          include: mutation_summary
```

---

## ğŸ—ï¸ AGENTIC ARCHITECTURE

### Agent Hierarchy

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                      ORCHESTRATOR AGENT (Master)                          â”‚
â”‚  â€¢ Coordinates all sub-agents                                             â”‚
â”‚  â€¢ Maintains patient state                                                â”‚
â”‚  â€¢ Handles inter-agent communication                                      â”‚
â”‚  â€¢ Manages event queue                                                    â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                                â”‚
        â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
        â”‚                       â”‚                       â”‚
        â–¼                       â–¼                       â–¼
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”    â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”    â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ DATA AGENTS   â”‚    â”‚ ANALYSIS      â”‚    â”‚ ACTION        â”‚
â”‚               â”‚    â”‚ AGENTS        â”‚    â”‚ AGENTS        â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤    â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤    â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚â€¢ Extractor    â”‚    â”‚â€¢ Biomarker    â”‚    â”‚â€¢ Notification â”‚
â”‚â€¢ Parser       â”‚    â”‚â€¢ Resistance   â”‚    â”‚â€¢ Plan Update  â”‚
â”‚â€¢ Validator    â”‚    â”‚â€¢ Drug Ranking â”‚    â”‚â€¢ Trial Match  â”‚
â”‚â€¢ Normalizer   â”‚    â”‚â€¢ Trial Match  â”‚    â”‚â€¢ Report Gen   â”‚
â”‚               â”‚    â”‚â€¢ Nutrition    â”‚    â”‚â€¢ Export       â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜    â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜    â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### Agent Communication Protocol

```python
# Agent Message Format
class AgentMessage:
    sender: str           # Agent ID
    recipient: str        # Target agent or "broadcast"
    message_type: str     # "request", "response", "event", "alert"
    payload: dict         # Data
    correlation_id: str   # For request-response matching
    timestamp: datetime
    priority: int         # 1=highest, 5=lowest

# Example: Biomarker Agent â†’ Resistance Agent
AgentMessage(
    sender="biomarker_agent",
    recipient="resistance_agent",
    message_type="event",
    payload={
        "event": "biomarker_calculated",
        "patient_id": "AYE-001",
        "data": {
            "tmb": 3.2,
            "tmb_classification": "TMB-L",
            "hrd_status": "HRD-INFERRED"
        }
    },
    correlation_id="calc-001",
    priority=2
)
```

### State Management

```python
# Central Patient State (maintained by Orchestrator)
class PatientState:
    patient_id: str
    profile: PatientProfile
    biomarkers: BiomarkerProfile
    resistance: ResistancePrediction
    drug_ranking: List[DrugRanking]
    trials: List[TrialMatch]
    nutrition: NutritionPlan
    care_plan: UnifiedCarePlan
    monitoring: MonitoringConfig
    alerts: List[Alert]
    history: List[StateChange]
    last_updated: datetime
    
    def on_change(self, field: str, old_value, new_value):
        """Triggered when any field changes"""
        # Log state change
        self.history.append(StateChange(field, old_value, new_value))
        # Evaluate triggers
        self.evaluate_triggers(field, new_value)
        # Notify relevant agents
        self.broadcast_change(field, new_value)
```

---

## ğŸ–¥ï¸ USER INTERFACE INTEGRATION

### Dashboard Layout

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  ğŸ§¬ CrisPRO.ai                              [Ayesha Kiani] [âš™ï¸] [ğŸ‘¤]  â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                         â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”‚
â”‚  â”‚  ğŸ”” ALERTS (2)                                            [â–¼]   â”‚   â”‚
â”‚  â”‚  â€¢ âš ï¸ CA-125 baseline still missing - ORDER IMMEDIATELY         â”‚   â”‚
â”‚  â”‚  â€¢ â„¹ï¸ New trial match: NCT05678901 (PARP + ATR) - 94% fit       â”‚   â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â”‚
â”‚                                                                         â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”‚
â”‚  â”‚  ğŸ“Š MOLECULAR        â”‚  â”‚  ğŸ’Š TREATMENT RECOMMENDATIONS         â”‚   â”‚
â”‚  â”‚  PROFILE             â”‚  â”‚                                      â”‚   â”‚
â”‚  â”‚                      â”‚  â”‚  1. Olaparib (PARP)     [0.94] â­    â”‚   â”‚
â”‚  â”‚  MBD4: c.1239delA â­ â”‚  â”‚     Tier I | High confidence        â”‚   â”‚
â”‚  â”‚  TP53: Mutant (IHC)  â”‚  â”‚                                      â”‚   â”‚
â”‚  â”‚  TMB: â³ Pending     â”‚  â”‚  2. Carboplatin         [0.88]       â”‚   â”‚
â”‚  â”‚  HRD: Inferred       â”‚  â”‚     Tier I | Very high confidence   â”‚   â”‚
â”‚  â”‚  IO: Not eligible    â”‚  â”‚                                      â”‚   â”‚
â”‚  â”‚                      â”‚  â”‚  3. Niraparib (PARP)   [0.91]       â”‚   â”‚
â”‚  â”‚  [View Full Profile] â”‚  â”‚     Tier I | High confidence        â”‚   â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â”‚
â”‚                                                                         â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”‚
â”‚  â”‚  âš”ï¸ RESISTANCE       â”‚  â”‚  ğŸ”¬ CLINICAL TRIALS                  â”‚   â”‚
â”‚  â”‚                      â”‚  â”‚                                      â”‚   â”‚
â”‚  â”‚  Platinum: HIGH      â”‚  â”‚  NCT05678901                        â”‚   â”‚
â”‚  â”‚  sensitivity         â”‚  â”‚  PARP + ATR in DDR-Deficient OC     â”‚   â”‚
â”‚  â”‚                      â”‚  â”‚  Mechanism Fit: 94% â­               â”‚   â”‚
â”‚  â”‚  Risk: 14.5%         â”‚  â”‚  Status: RECRUITING                 â”‚   â”‚
â”‚  â”‚  (baseline)          â”‚  â”‚  [View Details] [Check Eligibility] â”‚   â”‚
â”‚  â”‚                      â”‚  â”‚                                      â”‚   â”‚
â”‚  â”‚  MAPK: Wild-type âœ…  â”‚  â”‚  NCT04729387                        â”‚   â”‚
â”‚  â”‚  NF1: Not detected   â”‚  â”‚  Olaparib + Cediranib               â”‚   â”‚
â”‚  â”‚                      â”‚  â”‚  Mechanism Fit: 88%                 â”‚   â”‚
â”‚  â”‚  [View Full Analysis]â”‚  â”‚  [View All 5 Matches]               â”‚   â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â”‚
â”‚                                                                         â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
â”‚  â”‚  ğŸ¥— NUTRITION PLAN                           ğŸ“… MONITORING       â”‚  â”‚
â”‚  â”‚                                                                  â”‚  â”‚
â”‚  â”‚  During Carboplatin:                         Next Steps:         â”‚  â”‚
â”‚  â”‚  â€¢ NAC 600mg post-infusion                  â˜ CA-125 baseline   â”‚  â”‚
â”‚  â”‚  â€¢ Vitamin D 2000 IU daily                  â˜ NGS results       â”‚  â”‚
â”‚  â”‚  â€¢ Avoid grapefruit                         â˜ HRD score         â”‚  â”‚
â”‚  â”‚                                              â˜ CT post-C3        â”‚  â”‚
â”‚  â”‚  [View Full Plan]                           [View Schedule]      â”‚  â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
â”‚                                                                         â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
â”‚  â”‚  ğŸ’¬ CoPilot                                              [Chat]  â”‚  â”‚
â”‚  â”‚  "Ask me anything about Ayesha's case..."                        â”‚  â”‚
â”‚  â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚  â”‚
â”‚  â”‚  â”‚ Quick: [Why PARP?] [Resistance risk?] [Trial eligibility?] â”‚  â”‚  â”‚
â”‚  â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚  â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
â”‚                                                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## ğŸ“¡ API ENDPOINTS

### Master Orchestration Endpoint

```yaml
POST /api/orchestrate/full
Description: Initiates full end-to-end pipeline
Input:
  patient_data: File | PatientProfile
  options:
    run_all: boolean
    async: boolean
Output:
  job_id: string
  status: "started"
  estimated_time: "45 seconds"
  webhook_url: string (for completion notification)
```

### Individual Agent Endpoints

```yaml
# Data Extraction
POST /api/agents/extract
Input: { file: File, file_type: string }
Output: { patient_profile: PatientProfile, quality_flags: string[] }

# Biomarker Calculation
POST /api/agents/biomarkers
Input: { mutations: Mutation[], options: BiomarkerOptions }
Output: { biomarker_profile: BiomarkerProfile }

# Resistance Prediction
POST /api/agents/resistance
Input: { mutations: Mutation[], current_treatment: string }
Output: { resistance_prediction: ResistancePrediction }

# Drug Ranking
POST /api/agents/drugs
Input: { patient_profile: PatientProfile, biomarkers: BiomarkerProfile }
Output: { drug_ranking: DrugRanking[] }

# Trial Matching
POST /api/agents/trials
Input: { mechanism_vector: float[7], disease: string }
Output: { trial_matches: TrialMatch[] }

# Nutrition
POST /api/agents/nutrition
Input: { drugs: string[], germline: GermlineProfile }
Output: { nutrition_plan: NutritionPlan }

# Care Plan Generation
POST /api/agents/care-plan
Input: { all_agent_outputs: AgentOutputs }
Output: { unified_care_plan: UnifiedCarePlan }

# Event Trigger
POST /api/events/trigger
Input: { event_type: string, data: any }
Output: { actions_taken: Action[], alerts_sent: Alert[] }
```

---

## ğŸ” SECURITY & COMPLIANCE

### Data Flow Security

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  SECURITY LAYERS                                                         â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                          â”‚
â”‚  Layer 1: Transport                                                      â”‚
â”‚  â€¢ TLS 1.3 for all API calls                                            â”‚
â”‚  â€¢ Certificate pinning                                                   â”‚
â”‚                                                                          â”‚
â”‚  Layer 2: Authentication                                                 â”‚
â”‚  â€¢ OAuth 2.0 / JWT tokens                                               â”‚
â”‚  â€¢ Multi-factor authentication                                           â”‚
â”‚  â€¢ Role-based access control (RBAC)                                     â”‚
â”‚                                                                          â”‚
â”‚  Layer 3: Data Encryption                                               â”‚
â”‚  â€¢ AES-256 encryption at rest                                           â”‚
â”‚  â€¢ Field-level encryption for PII                                       â”‚
â”‚  â€¢ Key rotation every 90 days                                           â”‚
â”‚                                                                          â”‚
â”‚  Layer 4: Audit                                                          â”‚
â”‚  â€¢ Complete audit trail of all actions                                  â”‚
â”‚  â€¢ Immutable logs (append-only)                                         â”‚
â”‚  â€¢ HIPAA-compliant data retention                                       â”‚
â”‚                                                                          â”‚
â”‚  Layer 5: Compliance                                                     â”‚
â”‚  â€¢ HIPAA / HITECH compliance                                            â”‚
â”‚  â€¢ SOC 2 Type II certification                                          â”‚
â”‚  â€¢ GDPR-ready (data portability, right to delete)                       â”‚
â”‚                                                                          â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## ğŸ“ˆ SUCCESS METRICS

### Product KPIs

| Metric | Target | Measurement |
|--------|--------|-------------|
| **Time to First Insight** | <60 seconds | Upload â†’ Care plan generated |
| **Alert Lead Time** | 3-6 weeks | Resistance alert before clinical PD |
| **Trial Match Accuracy** | >90% | Mechanism fit correlation with enrollment |
| **User Engagement** | >80% DAU | Daily active oncologists |
| **Alert Action Rate** | >70% | Alerts that result in clinical action |

### Clinical KPIs

| Metric | Target | Measurement |
|--------|--------|-------------|
| **Time to Treatment** | -20% | Days from diagnosis to first treatment |
| **Trial Enrollment** | +30% | Patients enrolled in matching trials |
| **Resistance Detection** | -4 weeks | Time to detect vs standard monitoring |
| **Treatment Response** | +15% | Response rate with optimized selection |

---

## ğŸ—“ï¸ IMPLEMENTATION ROADMAP

### Phase 1: Core Pipeline (Weeks 1-2)
- [ ] Data extraction agent (PDF, VCF, MAF parsing)
- [ ] Biomarker calculation agent (TMB, MSI, HRD)
- [ ] Resistance prediction agent (MAPK, DDR)
- [ ] Basic orchestrator

### Phase 2: Intelligence Layer (Weeks 3-4)
- [ ] Drug ranking agent (S/P/E framework)
- [ ] Trial matching agent (mechanism vector)
- [ ] Nutrition agent (drug-food interactions)
- [ ] Care plan generator

### Phase 3: Monitoring & Triggers (Weeks 5-6)
- [ ] Event trigger system
- [ ] Alert routing
- [ ] CA-125 kinetics monitor
- [ ] ctDNA mutation monitor

### Phase 4: UI Integration (Weeks 7-8)
- [ ] Dashboard components
- [ ] CoPilot integration
- [ ] Mobile notifications
- [ ] Report export

### Phase 5: Hardening (Weeks 9-10)
- [ ] Security audit
- [ ] Performance optimization
- [ ] Load testing
- [ ] Documentation

---

## ğŸ¯ THE ULTIMATE MOAT

### What No Competitor Has:

| Capability | Us | Competitors |
|------------|-----|-------------|
| **End-to-end orchestration** | âœ… Upload â†’ Care plan â†’ Monitoring | âŒ Fragmented tools |
| **Agentic intelligence** | âœ… Autonomous agents, triggers, alerts | âŒ Manual workflows |
| **Validated biomarkers** | âœ… TMB r=0.933, MAPK RR=1.97 | âŒ Unvalidated or black-box |
| **Mechanism-based matching** | âœ… 7D vector, mechanism fit | âŒ Keyword matching only |
| **Toxicity-nutrition integration** | âœ… Drug MoA â†’ Food recommendations | âŒ Generic advice |
| **Continuous monitoring** | âœ… Real-time triggers, early alerts | âŒ Point-in-time analysis |
| **Transparent reasoning** | âœ… Full provenance, auditable | âŒ Black-box AI |

### The Defensible Position:

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                         â”‚
â”‚  ğŸ† THE CRISPRO.AI MOAT                                                 â”‚
â”‚                                                                         â”‚
â”‚  Layer 1: VALIDATED SCIENCE                                             â”‚
â”‚  â€¢ TMB validated against 1,895 TCGA samples (r=0.933)                  â”‚
â”‚  â€¢ Resistance validated on 469 TCGA-OV patients (RR=1.97)              â”‚
â”‚  â€¢ S/P/E framework with real Evo2 integration                          â”‚
â”‚                                                                         â”‚
â”‚  Layer 2: INTEGRATED WORKFLOW                                           â”‚
â”‚  â€¢ Single upload â†’ Full intelligence                                    â”‚
â”‚  â€¢ All MOATs working together, not siloed                              â”‚
â”‚  â€¢ Unified care plan, not fragmented reports                           â”‚
â”‚                                                                         â”‚
â”‚  Layer 3: AGENTIC INTELLIGENCE                                          â”‚
â”‚  â€¢ Autonomous agents that don't sleep                                   â”‚
â”‚  â€¢ Event triggers that catch signals early                             â”‚
â”‚  â€¢ Continuous monitoring, not point-in-time                            â”‚
â”‚                                                                         â”‚
â”‚  Layer 4: CLINICAL INTEGRATION                                          â”‚
â”‚  â€¢ CoPilot for real-time assistance                                    â”‚
â”‚  â€¢ Dashboard for at-a-glance status                                    â”‚
â”‚  â€¢ Alerts that drive action                                            â”‚
â”‚                                                                         â”‚
â”‚  â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•   â”‚
â”‚  RESULT: Precision oncology that works while you sleep.                 â”‚
â”‚  â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•   â”‚
â”‚                                                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

**Document Status:** âœ… MASTER BLUEPRINT COMPLETE  
**Owner:** CrisPRO.ai Product Team  
**Next Review:** Weekly during implementation

---